AQST Exercise Disclosure
Korczynski Sherry · SEC Form 4 · Filed Sep 11, 2026
Exercise
Calculated transaction value
$0
Korczynski Sherry Chief Commercial Officer
AQST
Transaction date
Sep 9, 2026
Public filing date
Sep 11, 2026
Filing lag
Filed 2 days later
AQST daily price context
Close on/before transaction
$5.15
Sep 9, 2026
Close before public filing
$4.99
Sep 10, 2026
Return since public filing
-5.01%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualified Stock Option (right to buy) on Common Stock
- Quantity / price
- 8,750 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001214659-26-011596
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$68.86K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aquestive Therapeutics, Inc. AQST | Exercise | Sep 9, 2026 | $23.19K |
| Aquestive Therapeutics, Inc. AQST | Sale | Sep 9, 2026 | $45.67K |
| Aquestive Therapeutics, Inc. AQST Current | Exercise | Sep 9, 2026 | $0 |